ACUVUE® Contact Lenses FOR ASTIGMATISM

What might clearer vision1 look like?

Drag the circle below to explore the scene with full astigmatic correction.
Day view of the city with buildings background
Day view of the city with buildings background
Simulator Settings
Select Environment
DAYTIME
Prescription Settings
CYL
AXIS
1.JJV Data on File 2022. A randomized, controlled, partially subject masked, bilateral, dispensing 2x2 crossover study (n=161) comparing objective and subjective measures and visual quality of life in low astigmats using full astigmatism correction vs. best spherical equivalent lens correction.

Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use available on the Johnson & Johnson website www.e-IFU.com

PP2022MLT6594
Johnson & Johnson
Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the lnstructions for Use available on Johnson & Johnson website https://www.e-ifu.com/. Important Safety Information: ACUVUE Revitalens Multi-Purpose Disinfecting Solution (MPDS) is indicated for the care of soft (hydrophilic) contact lenses, including silicone hydrogel lenses. For detailed product information, including warnings and precautions, please consult the Instructions for Use. Failure to do so may result in serious eye infection or injury.  © Johnson & Johnson AB. 2025. All rights reserved. This site is published by Johnson & Johnson AB, which is solely responsible for its content. It is intended for use by Eye Care Professionals in Sweden. ACUVUE®, ACUVUE®2, 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® MOIST for ASTIGMATISM, 1-DAY ACUVUE® MOIST MULTIFOCAL, ACUVUE® OASYS,  ACUVUE® OASYS MULTIFOCAL, ACUVUE® OASYS for ASTIGMATISM, ACUVUE® OASYS 1-Day for ASTIGMATISM, ACUVUE® OASYS 1-Day, ACUVUE® OASYS MAX 1-Day, ACUVUE® OASYS MAX 1-Day MULTIFOCAL, ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM, ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, ACUVUE® VITA®, ACUVUE RevitaLens, HydraMax, TearStable, OptiBlue, HYDRACLEAR®, LACREON®, EYE-INSPIRED and HydraLuxe® are trademarks of Johnson & Johnson. Third-party trademarks used herein are trademarks of their respective owners. Last Update: July 2, 2025.